Mitchell & Pahl Private Wealth’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
Mitchell & Pahl Private Wealth's NVO Position: Q3 2026 in Review
Mitchell & Pahl Private Wealth increased its Novo Nordisk (NVO) stake by 9% in Q3 2026, buying an estimated $73.6K and bringing the position to 19,410 shares worth $736K. The position accounts for 0.27% of the portfolio, ranked #114.
Mitchell & Pahl Private Wealth first reported a position in NVO in Q4 2020 and has held it in 24 quarters since. The position peaked at $1.73M in Q2 2024. 1,085 funds tracked by Wall St. Rank hold NVO as of Q3 2026.
- Mitchell & Pahl Private Wealth held 19,410 shares of Novo Nordisk worth $736K as of Q3 2026.
- Mitchell & Pahl Private Wealth bought 1,596 Novo Nordisk shares in Q3 2026, an estimated $73.6K.
- Novo Nordisk made up 0.27% of Mitchell & Pahl Private Wealth's portfolio in Q3 2026, its #114 holding.
- Mitchell & Pahl Private Wealth first reported a position in Novo Nordisk in Q4 2020 and has held it in 24 quarters since.
- Mitchell & Pahl Private Wealth's Novo Nordisk position peaked at $1.73M in Q2 2024.
- 1,085 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2026.
Based on Mitchell & Pahl Private Wealth's 13F filing for Q3 2026, filed 14 Oct 2026.